Company profile
Schrodinger, Inc.
Pipeline6 assets
- SGR-1505SGR-1505 / MALT1 / Small Molecule / OncologyRelapsed/Refractory B-cell MalignanciesPhase 1Active
- SGR-3515SGR-3515 / PKMYT1 / Wee1 / Small Molecule / OncologyAdvanced Solid TumorsPhase 1Active
- SGR-4174SGR-4174 / SOS1 / Small Molecule / OncologyKRAS-driven CancersPreclinicalActive
- SGR-2921SGR-2921 / CDC7 / Small Molecule / OncologyAcute Myeloid Leukemia (AML) / Myelodysplastic Syndrome (MDS)Phase 1Discontinued
- ACCG-2671ACCG-2671 / Calcitonin Receptor (DACRA) / Small Molecule / MetabolicObesityPhase 1Active
- AJ1-11095AJ1-11095 / JAK2 / Small Molecule / HematologyMyelofibrosisPreclinicalActiveUS